Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1(1R,3S,5R)-2-(2-(3-acetyl-5-(2-methylpyrimidin-5-yl)-1H-indazol-1-yl)acetyl)-N-(6-bromo-3-methylpyridin-2-yl)-5-methyl-2-azabicyclo[3.1.0]hexane-3-carboxamide----[1] 11 💬
2250 mg CK-2017357----[2] 2, 11 💬
3500 mg CK-2017357----[2] 2, 11 💬
4[acetominofene]----[2] 11, 63 💬
5[ALN-CC5]----[2] 11, 62 💬
6[ALXN1210]----[6] 2, 11, 13, 50, 62, 66 💬
7[Amifampridina fosfato]----[2] 3, 11 💬
8[ARGX-113]----[3] 11, 35, 63 💬
9[IMVT-1401]----[1] 11 💬
10[JNJ-80202135]----[1] 11 💬
11[M281]----[3] 11, 53, 61 💬
12[N/A]----[11] 2, 11, 13, 20, 28, 46, 51, 61, 65, 97, 299 💬
13[NA]----[34] 3, 6, 11, 13, 14, 19, 28, 35, 41, 46, 49, 50, 53, 57, 62, 63, 65, 75, 79, 85, 90, 96, 97, 98, 113, 127, 162, 195, 223, 229, 251, 294, 299, 302 💬
14[REGN3918]----[2] 11, 62 💬
15[rituximab][1] Rituximab[1] Rituximab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[2] 11, 14 💬
16[RO5333787]----[2] 11, 13 💬
17[SAR442168]----[2] 11, 13 💬
18[TAK-079, TSF-021, TSF79]----[1] 11 💬
19[UCB7665][1] Rozanolixizumab[1] Rozanolixizumab 💬 --[2] 11, 63 💬
20Abatacept[1] Abatacept[1] Abatacept 💬 [2] CD80,
CD86 💬
[14] Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Graft-versus-host disease, IgSF CAM signaling, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬[28] 2, 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 223, 271, 284, 285, 300 💬
21Abatacept Injection[1] Abatacept[1] Abatacept 💬 [2] CD80,
CD86 💬
[14] Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Graft-versus-host disease, IgSF CAM signaling, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬[3] 11, 46, 107 💬
22Acetaminophen[1] Acetaminophen[1] Acetaminophen 💬 [2] PTGS1,
PTGS2 💬
[23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬[19] 11, 13, 19, 34, 35, 46, 49, 51, 63, 70, 77, 86, 96, 222, 231, 256, 271, 300, 337 💬
23Acetate[1] Acetate---[52] 1, 2, 6, 10, 11, 13, 22, 35, 40, 46, 49, 51, 60, 63, 64, 65, 66, 67, 70, 71, 73, 75, 76, 77, 78, 79, 81, 83, 85, 86, 88, 89, 90, 96, 97, 113, 145, 156, 158, 162, 171, 206, 222, 223, 224, 225, 227, 235, 251, 265, 298, 299 💬
24Acetylcholine[1] Acetylcholine[1] Acetylcholine chloride 💬 [21] CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5,
CHRNA1,
CHRNA10,
CHRNA2,
CHRNA3,
CHRNA4,
CHRNA5,
CHRNA6,
CHRNA7,
CHRNA9,
CHRNB1,
CHRNB2,
CHRNB3,
CHRNB4,
CHRND,
CHRNE,
CHRNG 💬
[17] Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, Virion - Ebolavirus, Lyssavirus and Morbillivirus, cAMP signaling pathway 💬[1] 11 💬
25Acotiamide[1] Acotiamide---[2] 11, 51 💬
26Addition of rituximab if recurrence[1] Rituximab[1] Rituximab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 11 💬
27ALN-CC5----[4] 11, 62, 66, 109 💬
28Aluminium[1] Aluminium---[2] 11, 46 💬
29Aluminum hydroxide[1] Aluminum hydroxide[3] Aluminum hydroxide ,
Algeldrate ,
Almagate 💬
--[1] 11 💬
30ALXN1210----[7] 2, 11, 13, 50, 62, 66, 109 💬
31ALXN1720----[1] 11 💬
32ALXN1830----[3] 11, 35, 61 💬
33ALXN2050----[3] 11, 62, 66 💬
34AMIFAMPRIDINA----[2] 3, 11 💬
35Amifampridina fosfato----[2] 3, 11 💬
36Amifampridine[1] Amifampridine[2] Amifampridine ,
Amifampridine phosphate 💬
[7] KCNA1,
KCNA2,
KCNA4,
KCNA6,
KCNC3,
KCND2,
KCND3 💬
[5] Cortisol synthesis and secretion, Cushing syndrome, IgSF CAM signaling, Serotonergic synapse, Spinocerebellar ataxia 💬[3] 3, 11, 12 💬
37Amifampridine (base) with modified release[1] Amifampridine[2] Amifampridine ,
Amifampridine phosphate 💬
[7] KCNA1,
KCNA2,
KCNA4,
KCNA6,
KCNC3,
KCND2,
KCND3 💬
[5] Cortisol synthesis and secretion, Cushing syndrome, IgSF CAM signaling, Serotonergic synapse, Spinocerebellar ataxia 💬[1] 11 💬
38Amifampridine Phosphate[1] Amifampridine[2] Amifampridine ,
Amifampridine phosphate 💬
[7] KCNA1,
KCNA2,
KCNA4,
KCNA6,
KCNC3,
KCND2,
KCND3 💬
[5] Cortisol synthesis and secretion, Cushing syndrome, IgSF CAM signaling, Serotonergic synapse, Spinocerebellar ataxia 💬[3] 3, 11, 12 💬
39Anito-cel----[1] 11 💬
40Anti-C5 antibody----[4] 11, 14, 62, 109 💬
41Anti-Thymocyte Globulin----[19] 11, 13, 14, 36, 40, 41, 42, 45, 46, 49, 51, 60, 62, 63, 65, 164, 283, 284, 285 💬
42Apraclonidine[1] Apraclonidine[2] Apraclonidine hydrochloride ,
Apraclonidine 💬
[3] ADRA2A,
ADRA2B,
ADRA2C 💬
[4] Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬[1] 11 💬
43Apraclonidine Hcl 0.5% Oph Soln[1] Apraclonidine[2] Apraclonidine hydrochloride ,
Apraclonidine 💬
[3] ADRA2A,
ADRA2B,
ADRA2C 💬
[4] Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬[1] 11 💬
44ARGX-113----[5] 11, 14, 35, 53, 63 💬
45ARGX-113Pharmaceutical Form: Concentrate for solution for infusion----[1] 11 💬
46Aritinercept----[1] 11 💬
47ATG (rabbit)[1] Rabbit---[1] 11 💬
48Autologous Hematopoietic Stem Cell Transplantation----[7] 11, 13, 14, 28, 49, 51, 84 💬
49AZA----[4] 11, 40, 96, 97 💬
50Azathioprine[1] Azathioprine[2] Azathioprine ,
Azathioprine sodium 💬
--[26] 6, 11, 13, 19, 35, 42, 43, 44, 45, 46, 49, 55, 57, 63, 65, 66, 84, 85, 93, 94, 95, 96, 97, 162, 223, 300 💬
51B-peptide-CRM197 conjugate----[1] 11 💬
52B007----[3] 11, 35, 222 💬
53BAFF-R CART----[2] 11, 14 💬
54Batoclimab[1] Batoclimab[1] Batoclimab 💬 --[2] 11, 14 💬
55Batoclimab 340 mg SC bi-weekly[1] Batoclimab[1] Batoclimab 💬 --[1] 11 💬
56Batoclimab 340 mg SC weekly[1] Batoclimab[1] Batoclimab 💬 --[2] 11, 14 💬
57Batoclimab 680 mg SC weekly[1] Batoclimab[1] Batoclimab 💬 --[1] 11 💬
58BBR 2778----[2] 11, 13 💬
59BELIMUMAB[1] Belimumab[1] Belimumab 💬 [1] TNFSF13B 💬 [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[17] 11, 13, 43, 44, 46, 48, 49, 50, 51, 53, 63, 66, 95, 222, 223, 296, 300 💬
60Benlysta (belimumab)[1] Belimumab[1] Belimumab 💬 [1] TNFSF13B 💬 [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[4] 11, 49, 53, 222 💬
61BENLYSTA® (belimumab)[1] Belimumab[1] Belimumab 💬 [1] TNFSF13B 💬 [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[4] 11, 63, 66, 222 💬
62Bexsero----[4] 11, 13, 62, 223 💬
63Blinatumomab[1] Blinatumomab[1] Blinatumomab 💬 [4] CD19,
CD3D,
CD3E,
CD3G 💬
[13] B cell receptor signaling pathway, Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬[4] 11, 46, 49, 222 💬
64BORTEZOMIB[1] Bortezomib[1] Bortezomib 💬 [1] PSMB5 💬 [8] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬[19] 11, 13, 26, 28, 46, 49, 51, 61, 63, 64, 66, 172, 222, 223, 228, 256, 283, 288, 331 💬
65Bu Zhong Yi Qi Tang----[1] 11 💬
66CABA-201----[5] 11, 13, 35, 49, 51 💬
67Carmustine[1] Carmustine[1] Carmustine 💬 --[5] 11, 13, 14, 28, 60 💬
68CC-97540----[5] 11, 13, 46, 49, 51 💬
69CD19-BCMA Targeted CAR-T Dose 1----[1] 11 💬
70CD19-BCMA Targeted CAR-T Dose 2----[1] 11 💬
71CD19-CAR-NK Cells Injection----[1] 11 💬
72CD19-directed humanised afucosylated monoclonal antibody----[1] 11 💬
73CD19/BCMA-targeted CAR-T cells----[3] 11, 13, 14 💬
74CD20/BCMA-directed CAR-T cells----[4] 11, 13, 49, 51 💬
75CELLCEPT----[7] 11, 13, 42, 43, 49, 222, 223 💬
76CellCept 500 mg----[1] 11 💬
77CellCept 500 mg film-coated tablets----[1] 11 💬
78CellCept 500 mg tablets----[1] 11 💬
79CellCept®500 mg tablets----[1] 11 💬
80Cemdisiran[1] Cemdisiran---[6] 11, 15, 62, 66, 109, 223 💬
81CFZ533----[4] 11, 46, 49, 53 💬
82Cizutamig----[4] 11, 46, 49, 97 💬
83CLADRIBINE[1] Cladribine[1] Cladribine 💬 [1] RRM1 💬 [4] Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬[3] 11, 13, 94 💬
84Cladribine High Dose[1] Cladribine[1] Cladribine 💬 [1] RRM1 💬 [4] Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬[1] 11 💬
85Cladribine Low Dose[1] Cladribine[1] Cladribine 💬 [1] RRM1 💬 [4] Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬[1] 11 💬
86Cladrybine----[1] 11 💬
87Claseprubart[1] Claseprubart---[2] 11, 14 💬
88CNP-106----[1] 11 💬
89Combination Product: Claseprubart[1] Claseprubart---[1] 11 💬
90Combination Product: Efgartigimod + Thymectomy----[1] 11 💬
91Combination Product: Efgartigimod PH20 SC----[2] 11, 51 💬
92Combination Product: Gefurulimab[1] Gefurulimab[1] Gefurulimab 💬 [1] C5 💬 [11] Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬[1] 11 💬
93Combination Product: Intravenous immunglobulin + Thymectomy----[1] 11 💬
94Corynebacterium diphtheriae[1] Corynebacterium diphtheriae---[1] 11 💬
95CT103A[1] CT103A---[4] 11, 13, 14, 16 💬
96CT103A cells[1] CT103A---[4] 11, 13, 14, 16 💬
97CV-MG01[1] CV-MG01---[1] 11 💬
98Cyclophosphamide[1] Cyclophosphamide[2] Cyclophosphamide ,
Cyclophosphamide 💬
--[50] 11, 13, 14, 16, 19, 20, 26, 28, 34, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 56, 60, 61, 62, 63, 65, 66, 84, 93, 96, 162, 164, 172, 205, 221, 222, 223, 224, 256, 265, 274, 283, 284, 285, 288, 326, 331 💬
99Cyclophosphamide and fludarabine[2] Cyclophosphamide,
Fludarabine
[4] Cyclophosphamide ,
Fludarabine phosphate ,
Cyclophosphamide ,
Fludarabine 💬
[1] RRM1 💬 [4] Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬[4] 11, 13, 14, 16 💬
100Cyclosporine[1] Cyclosporine[1] Cyclosporine 💬 [5] PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬
[33] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬[39] 11, 14, 19, 20, 28, 36, 40, 41, 42, 45, 46, 49, 50, 53, 56, 58, 60, 61, 62, 63, 64, 65, 67, 90, 95, 97, 107, 118, 162, 164, 222, 223, 226, 228, 234, 283, 284, 285, 302 💬
101Cytarabine[1] Cytarabine[2] Cytarabine ,
Cytarabine hydrochloride 💬
--[8] 11, 13, 14, 25, 34, 49, 60, 65 💬
102DAS-001----[1] 11 💬
103Decartes-08----[1] 11 💬
104Descartes-08----[3] 11, 49, 50 💬
105Diagnostic Test: Serum acetylcholine receptor antibody, erythrocyte deposition rate, hypersensitive C protein, neostigmine test,thymus CT, low frequency repeated nerve stimulation[2] Acetylcholine,
Neostigmine
[4] Neostigmine bromide ,
Neostigmine methylsulfate ,
Acetylcholine chloride ,
Neostigmine 💬
[22] ACHE,
CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5,
CHRNA1,
CHRNA10,
CHRNA2,
CHRNA3,
CHRNA4,
CHRNA5,
CHRNA6,
CHRNA7,
CHRNA9,
CHRNB1,
CHRNB2,
CHRNB3,
CHRNB4,
CHRND,
CHRNE,
CHRNG 💬
[18] Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Gastric acid secretion, Glycerophospholipid metabolism, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, Virion - Ebolavirus, Lyssavirus and Morbillivirus, cAMP signaling pathway 💬[1] 11 💬
106Difenidramina----[2] 11, 63 💬
107DIFENIDRAMINA CLORIDRATO----[3] 11, 19, 63 💬
108Diphenhydramine[1] Diphenhydramine[4] Diphenhydramine ,
Diphenhydramine hydrochloride ,
Diphenhydramine salicylate ,
Diphenhydramine citrate 💬
[1] HRH1 💬 [4] Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬[12] 11, 13, 19, 49, 51, 63, 70, 86, 96, 222, 256, 300 💬
109Diphenhydramine hydrochloride[1] Diphenhydramine[4] Diphenhydramine ,
Diphenhydramine hydrochloride ,
Diphenhydramine salicylate ,
Diphenhydramine citrate 💬
[1] HRH1 💬 [4] Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬[3] 11, 49, 222 💬
110Dose level 1 group----[1] 11 💬
111Dose level 2 group----[1] 11 💬
112Dose level 3 group----[1] 11 💬
113Dose level 4 group----[1] 11 💬
114ECULIZUMAB[1] Eculizumab[1] Eculizumab 💬 [1] C5 💬 [11] Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬[8] 11, 13, 14, 61, 62, 109, 221, 223 💬
115EFALIZUMAB[1] Efalizumab[1] Efalizumab 💬 [1] ITGAL 💬 [14] Cell adhesion molecule (CAM) interaction, Epstein-Barr virus infection, Human T-cell leukemia virus 1 infection, IgSF CAM signaling, Integrin signaling, Leukocyte transendothelial migration, Malaria, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Rap1 signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Staphylococcus aureus infection, Viral myocarditis 💬[10] 11, 13, 37, 46, 48, 53, 61, 95, 96, 221 💬
116Efgartigimod[1] Efgartigimod alfa[1] Efgartigimod alfa 💬 --[8] 11, 14, 35, 36, 53, 63, 64, 300 💬
117Efgartigimod + Telitacicept (1-week interval) group[1] Telitacicept---[1] 11 💬
118Efgartigimod + Telitacicept (2-week interval) group[1] Telitacicept---[1] 11 💬
119Efgartigimod administration----[1] 11 💬
120EFGARTIGIMOD ALFA[1] Efgartigimod alfa[1] Efgartigimod alfa 💬 --[7] 11, 13, 14, 35, 53, 63, 162 💬
121EFGARTIGIMOD ALFACAS Number: 1821402-21-4Current Sponsor code: ARGX-113Concentration unit: mg/ml milligram(s)/millilitreConcentration type: equalConcentration number: 20-----[1] 11 💬
122Efgartigimod IV[1] Efgartigimod alfa[1] Efgartigimod alfa 💬 --[3] 11, 63, 222 💬
123Efgartigimod IV or Efgartigimod PH20 SC----[1] 11 💬
124Efgartigimod PH20 SC[1] Efgartigimod alfa[1] Efgartigimod alfa 💬 --[7] 11, 14, 35, 50, 53, 63, 162 💬
125Empasiprubart[1] Empasiprubart[1] Empasiprubart 💬 [1] C2 💬 [6] Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Pertussis, Staphylococcus aureus infection, Systemic lupus erythematosus 💬[3] 11, 14, 50 💬
126Empasiprubart IV[1] Empasiprubart[1] Empasiprubart 💬 [1] C2 💬 [6] Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Pertussis, Staphylococcus aureus infection, Systemic lupus erythematosus 💬[3] 11, 14, 50 💬
127EN101----[1] 11 💬
128Ephedrine[1] Ephedrine[3] Ephedrine ,
Ephedrine hydrochloride ,
Ephedrine sulfate 💬
[9] ADRA1A,
ADRA1B,
ADRA1D,
ADRA2A,
ADRA2B,
ADRA2C,
ADRB1,
ADRB2,
ADRB3 💬
[16] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 11 💬
129EPHEDRINE HYDROCHLORIDE[1] Ephedrine[3] Ephedrine ,
Ephedrine hydrochloride ,
Ephedrine sulfate 💬
[9] ADRA1A,
ADRA1B,
ADRA1D,
ADRA2A,
ADRA2B,
ADRA2C,
ADRB1,
ADRB2,
ADRB3 💬
[16] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 11 💬
130Etomidate[1] Etomidate[1] Etomidate 💬 [1] GABRA1 💬 [8] Cadherin signaling, GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Taste transduction 💬[2] 6, 11 💬
131Etoposide[1] Etoposide[2] Etoposide ,
Etoposide phosphate 💬
--[12] 11, 13, 14, 26, 28, 34, 54, 60, 65, 85, 164, 331 💬
132EVM18001 Injection----[3] 11, 49, 51 💬
133Famciclovir[1] Famciclovir[1] Famciclovir 💬 --[2] 11, 13 💬
134Fc- and CDR-modified humanised monoclonal antibody against C5----[3] 11, 62, 109 💬
135FIRDAPSE - 10 MG - COMPRESSE - USO ORALE - BLISTER(ALU/PVC/PVDC) 100 X 1 COMPRESSE----[2] 3, 11 💬
136Fludarabine[1] Fludarabine[2] Fludarabine phosphate ,
Fludarabine 💬
[1] RRM1 💬 [4] Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬[30] 11, 13, 14, 16, 19, 28, 34, 35, 36, 44, 46, 49, 50, 51, 60, 61, 62, 63, 65, 85, 96, 107, 164, 222, 223, 283, 284, 285, 286, 326 💬
137G-CSF[1] Filgrastim[1] Filgrastim 💬 [1] CSF3R 💬 [5] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬[12] 6, 11, 13, 51, 60, 61, 63, 65, 85, 96, 284, 285 💬
138GALANTAMINE[1] Galantamine[2] Galantamine hydrobromide ,
Galantamine 💬
[1] ACHE 💬 [3] Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬[3] 6, 11, 127 💬
139GAMUNEX 10%----[1] 11 💬
140GB-0998 (Intravenous immunoglobulin)----[1] 11 💬
141GC012F[1] GC012F---[6] 11, 13, 28, 46, 49, 51 💬
142GC012F injection[1] GC012F---[4] 11, 28, 49, 51 💬
143Gefurulimab[1] Gefurulimab[1] Gefurulimab 💬 [1] C5 💬 [11] Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬[1] 11 💬
144Genetic: Genotype analysis for VDR rs1544410, rs2228570, rs731236, and rs7975232 polymorphisms----[1] 11 💬
145Genetic: YTB323----[1] 11 💬
146Gold[1] Gold---[71] 2, 5, 6, 11, 13, 17, 19, 21, 22, 28, 34, 35, 46, 49, 50, 53, 54, 56, 57, 58, 60, 63, 64, 65, 66, 68, 71, 75, 76, 77, 79, 84, 85, 86, 88, 91, 93, 95, 96, 97, 98, 107, 113, 127, 137, 158, 162, 167, 171, 193, 206, 215, 218, 222, 223, 224, 226, 227, 228, 230, 235, 271, 291, 294, 296, 298, 299, 310, 318, 331, 340 💬
147Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)----[1] 11 💬
148GSK1550188----[5] 11, 49, 63, 66, 222 💬
149HBI0101 CART----[5] 11, 13, 46, 49, 51 💬
150HBM9161 Injection (340 mg)----[1] 11 💬
151HBM9161 Injection (680mg and 340 mg)----[1] 11 💬
152HBM9161 Injection (680mg)----[1] 11 💬
153Hematopoietic Stem Cell Transplantation----[13] 11, 13, 14, 19, 20, 35, 46, 49, 51, 65, 96, 234, 285 💬
154Hidrocloruro de efedrina[1] Ephedrine[3] Ephedrine ,
Ephedrine hydrochloride ,
Ephedrine sulfate 💬
[9] ADRA1A,
ADRA1B,
ADRA1D,
ADRA2A,
ADRA2B,
ADRA2C,
ADRB1,
ADRB2,
ADRB3 💬
[16] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 11 💬
155HIZENTRA ®----[1] 11 💬
156HN2301 injection----[4] 11, 46, 49, 51 💬
157HN2302 Injection----[3] 11, 49, 51 💬
158HUMAN NORMAL IMMUNOGLOBULIN (IV)----[4] 11, 14, 63, 65 💬
159Human normal immunoglobulin G (IgG)----[1] 11 💬
160Humanised VHH-type bispecific antibody against Complement component 5 and serum albumin----[1] 11 💬
161Humanised VHH-type bispecific antibody that binds to Complement component 5 and serum albumin----[1] 11 💬
162IGIV-C----[1] 11 💬
163IM-101 Part A----[1] 11 💬
164IM-101 Part B----[1] 11 💬
165Immediate treatment with corticosteroids----[1] 11 💬
166Immediate-Release Tablets----[1] 11 💬
167Immune globulin----[3] 11, 13, 14 💬
168Immune Globulin (Human), 10% Caprylate/Chromatography Purified----[1] 11 💬
169Immune Globulin (Human), 10% Caprylate/Chromatography Purified (IGIV-C)----[1] 11 💬
170IMMUNOGLOBULIN G----[9] 2, 11, 13, 14, 36, 49, 50, 63, 65 💬
171IMVT-1401----[2] 11, 14 💬
172IMVT-1402[1] IMVT-1402---[3] 11, 46, 53 💬
173INEBILIZUMAB[1] Inebilizumab[1] Inebilizumab 💬 [1] CD19 💬 [5] B cell receptor signaling pathway, Epstein-Barr virus infection, Hematopoietic cell lineage, PI3K-Akt signaling pathway, Primary immunodeficiency 💬[8] 11, 13, 46, 49, 51, 53, 95, 300 💬
174Influenza vaccine----[6] 11, 13, 46, 51, 84, 97 💬
175Intravenous ImmuneGlobulin----[1] 11 💬
176Intravenous immunoglobulin + subcutaneous immunoglobulin (SCIG)----[1] 11 💬
177Iptacopan[1] Iptacopan[2] Iptacopan ,
Iptacopan hydrochloride 💬
[1] CFB 💬 [3] Complement and coagulation cascades, Coronavirus disease, Staphylococcus aureus infection 💬[8] 11, 61, 62, 63, 66, 109, 222, 223 💬
178IV efgartigimod----[1] 11 💬
179IVIG----[8] 11, 13, 14, 18, 51, 63, 65, 172 💬
180IVIG (Intravenous Immunoglobulin)----[2] 11, 14 💬
181JNJ-80202135----[5] 11, 14, 46, 49, 53 💬
182KITE-363----[5] 11, 13, 14, 49, 51 💬
183KYV-101[1] KYV-101---[5] 11, 13, 46, 50, 51 💬
184LCAR-AIO T cells----[3] 11, 13, 49 💬
185Leflunomide[1] Leflunomide[1] Leflunomide 💬 [1] DHODH 💬 [1] Pyrimidine metabolism 💬[14] 11, 40, 46, 49, 53, 54, 66, 107, 162, 223, 224, 270, 271, 300 💬
186LVIVO-TaVec400 product----[4] 11, 13, 49, 300 💬
187Lymphodepleting Conditioning----[3] 11, 13, 14 💬
188M281----[5] 11, 46, 49, 53, 61 💬
189M281 Injection----[1] 11 💬
190Mabthera----[20] 11, 13, 35, 43, 44, 45, 46, 50, 51, 52, 53, 61, 63, 64, 65, 83, 162, 222, 223, 271 💬
191Magnesium[1] Magnesium---[23] 3, 6, 11, 13, 15, 46, 64, 70, 71, 93, 97, 113, 166, 225, 234, 235, 256, 284, 291, 296, 297, 298, 340 💬
192Magnesium sulfate[2] Magnesium,
Magnesium sulfate
[1] Magnesium sulfate 💬 --[4] 11, 97, 296, 297 💬
193Melphalan[1] Melphalan[2] Melphalan ,
Melphalan hydrochloride 💬
--[19] 11, 13, 14, 19, 20, 28, 34, 46, 60, 62, 65, 96, 107, 164, 222, 234, 284, 285, 299 💬
194MENINGOCOCCAL GROUP A OLIGOSACCHARIDES CONJUGATED TO CORYNEBACTERIUM DIPHTHERIAE C7 (beta197) M8 (CRM197) PROTEIN[1] Corynebacterium diphtheriae---[1] 11 💬
195MENINGOCOCCAL GROUP A OLIGOSACCHARIDES CONJUGATED TO CORYNEBACTERIUM DIPHTHERIAE C7 (ß197) M8 (CRM197) PROTEIN[1] Corynebacterium diphtheriae---[1] 11 💬
196MENINGOCOCCAL GROUP W OLIGOSACCHARIDES CONJUGATED TO CORYNEBACTERIUM DIPHTHERIAE C7 (beta197) M8 (CRM197) PROTEIN[1] Corynebacterium diphtheriae---[1] 11 💬
197MENINGOCOCCAL GROUP W OLIGOSACCHARIDES CONJUGATED TO CORYNEBACTERIUM DIPHTHERIAE C7 (ß197) M8 (CRM197) PROTEIN[1] Corynebacterium diphtheriae---[1] 11 💬
198MENINGOCOCCAL GROUP Y OLIGOSACCHARIDES CONJUGATED TO CORYNEBACTERIUM DIPHTHERIAE C7 (Â197) M8 (CRM197) PROTEIN[1] Corynebacterium diphtheriae---[1] 11 💬
199Menveo----[4] 11, 13, 62, 223 💬
200Mesna[1] Coenzyme M[1] Mesna 💬 --[12] 11, 13, 16, 44, 45, 49, 51, 60, 65, 85, 96, 164 💬
201Mestinon----[3] 3, 6, 11 💬
202Methotrexate[1] Methotrexate[2] Methotrexate ,
Methotrexate sodium 💬
[2] DHFR,
DHFR2 💬
[3] Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate 💬[41] 11, 13, 14, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 54, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 223, 240, 256, 270, 271, 284, 285, 286, 326, 331 💬
203Methylprednisolone[1] Methylprednisolone[2] Methylprednisolone ,
Methylprednisolone acetate 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[51] 2, 6, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 95, 96, 97, 111, 127, 145, 162, 164, 211, 222, 223, 224, 271, 283, 284, 285, 296, 300 💬
204Metilprdnisolone----[1] 11 💬
205METILPREDNISOLONE----[5] 11, 53, 56, 63, 300 💬
206MONARSEN[1] Monarsen---[1] 11 💬
207MTM-H-001 Injection----[3] 11, 13, 46 💬
208MuSK-CAART----[1] 11 💬
209Mutagrip----[2] 11, 13 💬
210Mycophenolate mofetil[2] Mycophenolate mofetil,
Mycophenolic acid
[4] Mycophenolate mofetil ,
Mycophenolate mofetil hydrochloride ,
Mycophenolate sodium ,
Mycophenolic acid 💬
[2] IMPDH1,
IMPDH2 💬
[2] Drug metabolism - other enzymes, Purine metabolism 💬[38] 2, 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 45, 46, 49, 51, 53, 57, 60, 61, 62, 63, 65, 66, 93, 95, 96, 118, 162, 164, 222, 223, 224, 226, 234, 283, 284, 285, 300 💬
211Mycophenolate mofetil (CellCept)[1] Mycophenolate mofetil[2] Mycophenolate mofetil ,
Mycophenolate mofetil hydrochloride 💬
[2] IMPDH1,
IMPDH2 💬
[2] Drug metabolism - other enzymes, Purine metabolism 💬[3] 11, 13, 223 💬
212Mycophenolate mofetil [CellCept][1] Mycophenolate mofetil[2] Mycophenolate mofetil ,
Mycophenolate mofetil hydrochloride 💬
[2] IMPDH1,
IMPDH2 💬
[2] Drug metabolism - other enzymes, Purine metabolism 💬[1] 11 💬
213Mycophenolic acid[1] Mycophenolic acid[2] Mycophenolate sodium ,
Mycophenolic acid 💬
[2] IMPDH1,
IMPDH2 💬
[2] Drug metabolism - other enzymes, Purine metabolism 💬[9] 11, 43, 49, 51, 60, 66, 96, 222, 223 💬
214N. MENINGITIDIS GROUP C (STRAIN C11) OLIGOSACCHARIDE CONJUGATED TO----[1] 11 💬
215N. MENINGITIDIS GROUP C (STRAIN C11) OLIGOSACCHARIDE CONJUGATED TO CORYNEBACTERIUM DIPHTHERIAE CRM197 ADSORBED ON ALUMINUM HYDROXIDE[2] Aluminum hydroxide,
Corynebacterium diphtheriae
[3] Aluminum hydroxide ,
Algeldrate ,
Almagate 💬
--[1] 11 💬
216Neostigmine[1] Neostigmine[3] Neostigmine bromide ,
Neostigmine methylsulfate ,
Neostigmine 💬
[1] ACHE 💬 [3] Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬[1] 11 💬
217Nipocalimab[1] Nipocalimab[1] Nipocalimab 💬 --[6] 11, 14, 46, 49, 53, 61 💬
218Nipocalimab Product Code: JNJ-80202135Pharmaceutical Form: Solution for infusionINN or Proposed INN: NipocalimabCAS Number: 2211985-36-1Current Sponsor code: JNJ-80202135Other descriptive name: M281Concentration unit: mg/ml milligram(s)/millilitreConcentration type: equalConcentration number: 30-Pharmaceutical form of the placebo: Solution for infusionRoute of administration of the placebo: Intravenous use[1] Nipocalimab[1] Nipocalimab 💬 --[1] 11 💬
219Nipocalimab SC-LIV[1] Nipocalimab[1] Nipocalimab 💬 --[1] 11 💬
220NMD670----[3] 3, 10, 11 💬
221Ocrelizumab[1] Ocrelizumab[1] Ocrelizumab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[4] 11, 13, 46, 49 💬
222Ofatumumab[1] Ofatumumab[1] Ofatumumab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[6] 11, 13, 35, 46, 222, 223 💬
223Oral Corticosteroid Tapering Schedule----[1] 11 💬
224Other: Blood draw----[17] 2, 6, 11, 13, 18, 39, 46, 57, 77, 84, 85, 86, 88, 96, 97, 167, 299 💬
225Other: Blood sample----[37] 2, 11, 13, 34, 35, 41, 44, 46, 48, 49, 50, 51, 53, 58, 61, 63, 65, 84, 86, 96, 97, 113, 160, 162, 177, 222, 223, 227, 234, 238, 240, 256, 279, 299, 335, 340, 348 💬
226Other: Blood Sample Draw----[1] 11 💬
227Other: Cheek swab----[2] 11, 13 💬
228Other: early use of Ravulizumab[1] Ravulizumab[1] Ravulizumab 💬 [1] C5 💬 [11] Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬[1] 11 💬
229Other: Laboratory Biomarker Analysis----[22] 11, 13, 14, 26, 28, 34, 40, 49, 51, 60, 62, 65, 89, 96, 97, 205, 232, 283, 284, 285, 298, 331 💬
230Other: Patients diagnosed with generalized myasthenia gravis and treated with Rozanolixizumab[1] Rozanolixizumab[1] Rozanolixizumab 💬 --[1] 11 💬
231Other: Withdraw all immunosuppresants----[1] 11 💬
232Outer membrane vesicles (OMV) from Neisseria meningitidis group B strain NZ98/254measured as amount of total protein containing the PorA P1.4----[1] 11 💬
233Oxaloacetate----[1] 11 💬
234PARACETAMOLO----[10] 2, 11, 14, 19, 28, 53, 61, 63, 300, 309 💬
235Peripheral Blood Stem Cell Transplantation----[12] 11, 13, 14, 28, 51, 60, 62, 65, 283, 284, 285, 286 💬
236PIXANTRONE[1] Pixantrone[2] Pixantrone ,
Pixantrone dimaleate 💬
--[2] 11, 13 💬
237Plasma exchange (PE)----[6] 11, 13, 64, 66, 221, 223 💬
238Plasmapheresis----[4] 11, 49, 113, 222 💬
239PLEX----[1] 11 💬
240Povetacicept[1] Povetacicept[1] Povetacicept 💬 [1] TNFRSF13B 💬 [3] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, Primary immunodeficiency 💬[5] 11, 61, 63, 66, 222 💬
241Pozelimab[1] Pozelimab[1] Pozelimab 💬 [1] C5 💬 [11] Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬[3] 11, 15, 62 💬
242Pozelimab + Cemdisiran[2] Cemdisiran,
Pozelimab
[1] Pozelimab 💬 [1] C5 💬 [11] Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬[1] 11 💬
243PREDNISOLONE[1] Prednisolone[1] Prednisolone 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[48] 3, 11, 13, 14, 18, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 54, 56, 57, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 107, 111, 113, 145, 162, 222, 223, 251, 269, 271, 296, 299, 300 💬
244Prednisone[1] Prednisone[1] Prednisone 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[58] 2, 11, 13, 14, 18, 19, 26, 28, 35, 40, 41, 42, 43, 44, 45, 46, 48, 49, 50, 51, 53, 60, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 90, 93, 95, 96, 97, 113, 127, 145, 162, 164, 205, 222, 223, 224, 228, 251, 269, 283, 284, 285, 288, 299, 300, 303, 307, 331 💬
245Prednisone - Azathioprine[2] Azathioprine,
Prednisone
[3] Azathioprine ,
Prednisone ,
Azathioprine sodium 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 11 💬
246Prednisone alone[1] Prednisone[1] Prednisone 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[2] 11, 66 💬
247Prednisone/Prednisolone[2] Prednisolone,
Prednisone
[2] Prednisolone ,
Prednisone 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[2] 11, 35 💬
248PRIVIGEN----[6] 11, 14, 51, 63, 65, 222 💬
249PRN2246----[2] 11, 13 💬
250Pyridostigmine[1] Pyridostigmine[1] Pyridostigmine bromide 💬 [1] ACHE 💬 [3] Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬[5] 3, 6, 11, 51, 256 💬
251Pyridostigmine Bromide[1] Pyridostigmine[1] Pyridostigmine bromide 💬 [1] ACHE 💬 [3] Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬[5] 3, 6, 11, 51, 256 💬
252Pyridostigmine, Prednisone, Tacrolimus[3] Prednisone,
Pyridostigmine,
Tacrolimus
[4] Tacrolimus ,
Prednisone ,
Pyridostigmine bromide ,
Tacrolimus 💬
[7] ACHE,
NR3C1,
PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬
[37] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Cholinergic synapse, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Glycerophospholipid metabolism, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬[1] 11 💬
253Pyridostigmine, Tacrolimus[2] Pyridostigmine,
Tacrolimus
[3] Tacrolimus ,
Pyridostigmine bromide ,
Tacrolimus 💬
[6] ACHE,
PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬
[36] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Cholinergic synapse, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Glycerophospholipid metabolism, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Neuroactive ligand signaling, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬[1] 11 💬
254QT-019C----[5] 11, 13, 49, 51, 63 💬
255Rabbit[1] Rabbit---[11] 11, 13, 49, 51, 60, 62, 65, 96, 283, 285, 326 💬
256Raptiva 100 mg/ml powder and solvent for solution for injection----[9] 11, 13, 46, 48, 53, 61, 95, 96, 221 💬
257RAVULIZUMAB[1] Ravulizumab[1] Ravulizumab 💬 [1] C5 💬 [11] Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬[8] 2, 11, 13, 50, 62, 66, 109, 224 💬
258RC18 160mg----[3] 11, 13, 66 💬
259RC18 240 mg----[2] 11, 53 💬
260RECOMBINANT NEISSERIA----[1] 11 💬
261RECOMBINANT NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN PRODUCED IN E.COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE[1] Aluminium---[1] 11 💬
262RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN----[1] 11 💬
263RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN----[2] 11, 13 💬
264REGN3918----[2] 11, 62 💬
265Remibrutinib[1] Remibrutinib[1] Remibrutinib 💬 [1] BTK 💬 [7] B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬[3] 11, 13, 53 💬
266Remibrutinib (Blinded)[1] Remibrutinib[1] Remibrutinib 💬 [1] BTK 💬 [7] B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬[2] 11, 13 💬
267Remibrutinib (Open Label)[1] Remibrutinib[1] Remibrutinib 💬 [1] BTK 💬 [7] B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬[2] 11, 13 💬
268Ripertamab[1] Ripertamab---[4] 11, 14, 63, 222 💬
269RITUXIMAB[1] Rituximab[1] Rituximab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[54] 11, 13, 14, 19, 26, 34, 35, 36, 40, 41, 42, 43, 44, 45, 46, 48, 49, 50, 51, 52, 53, 55, 56, 60, 61, 62, 63, 64, 65, 66, 83, 84, 85, 86, 88, 93, 94, 96, 97, 162, 172, 222, 223, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬
270Rituximab (Rituxan)[1] Rituximab[1] Rituximab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 11 💬
271Rituximab Injection[1] Rituximab[1] Rituximab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[3] 11, 35, 222 💬
272RO 533-3787/F01-06----[1] 11 💬
273RO5333787----[2] 11, 13 💬
274ROZANOLIXIZUMAB[1] Rozanolixizumab[1] Rozanolixizumab 💬 --[3] 11, 14, 63 💬
275RVT-1401----[3] 11, 14, 61 💬
276RVT-1401, HL161BKN, HBM9161----[1] 11 💬
277Salbutamol----[9] 2, 3, 11, 85, 86, 228, 256, 299, 340 💬
278Salbutamol 4Mg Tablet----[1] 11 💬
279SALBUTAMOL SULFATE PH. EUR.----[1] 11 💬
280Salbutamol WZF 4 mg----[1] 11 💬
281SAR442168----[2] 11, 13 💬
282SATRALIZUMAB[1] Satralizumab[1] Satralizumab 💬 [1] IL6R 💬 [11] Coronavirus disease, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬[4] 11, 13, 86, 113 💬
283SHR-2173 injection----[5] 11, 49, 63, 66, 222 💬
284Sodium chloride[1] Sodium chloride[1] Sodium chloride 💬 --[31] 2, 6, 11, 13, 14, 22, 34, 41, 46, 50, 51, 53, 60, 65, 67, 70, 85, 96, 97, 124, 168, 193, 214, 215, 226, 227, 228, 271, 288, 298, 299 💬
285Sodium Chloride solution[1] Sodium chloride[1] Sodium chloride 💬 --[4] 11, 13, 51, 228 💬
286SOLIRIS----[6] 11, 13, 14, 62, 109, 223 💬
287Standard Lymphodepletion regimen----[3] 11, 13, 51 💬
288Standard of Care Treatment----[6] 11, 49, 53, 96, 245, 246 💬
289Steroid Drug----[3] 11, 46, 49 💬
290Subcutaneous immunoglobulin (SCIG)----[1] 11 💬
291Subcutaneous immunoglobulins----[1] 11 💬
292Sufentanil[1] Sufentanil[2] Sufentanil citrate ,
Sufentanil 💬
[1] OPRM1 💬 [5] Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬[5] 11, 22, 46, 70, 280 💬
293Sugammadex[1] Sugammadex[1] Sugammadex sodium 💬 --[1] 11 💬
294Sustained-Release Tablets----[1] 11 💬
295Symptomatic Treatment, Steroids, Immunosuppressive Agents( azathioprine, tacrolimus, Mycophenolate Mofetil)[3] Azathioprine,
Mycophenolate mofetil,
Tacrolimus
[6] Tacrolimus ,
Azathioprine ,
Mycophenolate mofetil ,
Azathioprine sodium ,
Mycophenolate mofetil hydrochloride ,
Tacrolimus 💬
[7] IMPDH1,
IMPDH2,
PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬
[35] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Drug metabolism - other enzymes, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Purine metabolism, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬[1] 11 💬
296Symptomatic Treatment, Steroids, Immunosuppressive Agents, Plasma Exchange(PE), Intravenous Immunoglobulin(IVIg)----[1] 11 💬
297Syngeneic Bone Marrow Transplantation----[3] 11, 13, 14 💬
298SYS6020 injection----[1] 11 💬
299T-peptide-CRM197 conjugate----[1] 11 💬
300Tacrolimus[1] Tacrolimus[2] Tacrolimus ,
Tacrolimus 💬
[5] PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬
[33] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬[37] 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 57, 60, 61, 62, 63, 65, 66, 95, 96, 97, 113, 151, 158, 164, 222, 223, 224, 226, 227, 228, 234, 283, 284, 285, 286, 299 💬
301Tacrolimus capsule[1] Tacrolimus[2] Tacrolimus ,
Tacrolimus 💬
[5] PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬
[33] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬[1] 11 💬
302TAK-079----[3] 11, 49, 63 💬
303Talquetamab[1] Talquetamab[1] Talquetamab 💬 [1] CD3E 💬 [11] Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬[2] 11, 28 💬
304Telitacicept[1] Telitacicept---[14] 11, 13, 14, 46, 48, 49, 51, 53, 63, 66, 162, 222, 223, 300 💬
305Telitacicept-only group[1] Telitacicept---[1] 11 💬
306Tetanus vaccin----[1] 11 💬
307Thymectomy plus prednisone[1] Prednisone[1] Prednisone 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 11 💬
308Tocilizumab[1] Tocilizumab[1] Tocilizumab 💬 [1] IL6R 💬 [11] Coronavirus disease, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬[26] 2, 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 65, 86, 107, 149, 153, 223, 266, 271, 298, 331 💬
309Tocilizumab Injectable Product[1] Tocilizumab[1] Tocilizumab 💬 [1] IL6R 💬 [11] Coronavirus disease, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬[1] 11 💬
310Tocilizumab Injection[1] Tocilizumab[1] Tocilizumab 💬 [1] IL6R 💬 [11] Coronavirus disease, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬[2] 11, 13 💬
311Tofacitinib[1] Tofacitinib[2] Tofacitinib citrate ,
Tofacitinib 💬
[4] JAK1,
JAK2,
JAK3,
TYK2 💬
[39] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬[23] 2, 11, 35, 38, 39, 40, 44, 46, 49, 50, 51, 53, 56, 65, 66, 84, 96, 97, 107, 110, 162, 271, 300 💬
312Tofacitinib 5 MG[1] Tofacitinib[2] Tofacitinib citrate ,
Tofacitinib 💬
[4] JAK1,
JAK2,
JAK3,
TYK2 💬
[39] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬[5] 11, 40, 46, 50, 271 💬
313Tolebrutinib[1] Tolebrutinib[1] Tolebrutinib 💬 [1] BTK 💬 [7] B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬[2] 11, 13 💬
314Tolebrutininb----[1] 11 💬
315UCAR T-cell----[7] 11, 13, 14, 49, 51, 66, 222 💬
316UCAR T-cell group----[3] 11, 49, 61 💬
317UCB7665[1] Rozanolixizumab[1] Rozanolixizumab 💬 --[3] 11, 14, 63 💬
318Ultomiris----[7] 2, 11, 13, 50, 62, 66, 109 💬
319Ultomiris 1,100 mg/11 mL----[1] 11 💬
320Universal allogeneic anti-CD19/BCMA CAR T-cells----[4] 11, 49, 51, 61 💬
321Universal BCMA CAR-T----[3] 11, 13, 14 💬
322Universal CD19 CAR-?dT Cell Injection----[3] 11, 13, 14 💬
323Universal CD19 CAR-T----[3] 11, 13, 14 💬
324Uplizna----[3] 11, 13, 300 💬
325Velamox----[1] 11 💬
326Velcade®----[1] 11 💬
327Zilbrysq----[1] 11 💬
328Zilucoplan[1] Zilucoplan[2] Zilucoplan sodium ,
Zilucoplan 💬
[1] C5 💬 [11] Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬[3] 2, 11, 62 💬
329Zilucoplan (RA101495)[1] Zilucoplan[2] Zilucoplan sodium ,
Zilucoplan 💬
[1] C5 💬 [11] Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬[2] 11, 62 💬
330Zilucoplan®[1] Zilucoplan[2] Zilucoplan sodium ,
Zilucoplan 💬
[1] C5 💬 [11] Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬[1] 11 💬